Development of Antisense Drugs for Dyslipidemia.
作者： Tsuyoshi Yamamoto , Fumito Wada , Mariko Harada-Shiba
DOI: 10.5551/JAT.RV16001
关键词:
摘要: … Ⅲ APPROACH trial for evaluation of volanesorsen was started in patients with FCS. This trial … an 85% reduction in liver PCSK9 mRNA and serum PCSK9 protein and a 50% reduction in …
sci-hub.se 参考文章(131)
Sotirios Tsimikas, Jennifer L. Hall, Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. Journal of the American College of Cardiology. ,vol. 60, pp. 716- 721 ,(2012) , 10.1016/J.JACC.2012.04.038
Shin-Ichiro Hori, Tsuyoshi Yamamoto, Satoshi Obika, XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides. Biochemical and Biophysical Research Communications. ,vol. 464, pp. 506- 511 ,(2015) , 10.1016/J.BBRC.2015.06.171
Thazha P. Prakash, W. Brad Wan, Audrey Low, Jinghua Yu, Alfred E. Chappell, Hans Gaus, Garth A. Kinberger, Michael E. Østergaard, Michael T. Migawa, Eric E. Swayze, Punit P. Seth, Solid-phase synthesis of 5′-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 4127- 4130 ,(2015) , 10.1016/J.BMCL.2015.08.019
Kazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, Yumiko Sujino, Tomoko Nishina, Tsuyoshi Yamamoto, Keiko Nitta, Kotaro Yoshioka, Hiroya Kuwahara, Hidenori Yasuhara, Takeshi Baba, Fumiko Ono, Kanjiro Miyata, Koichi Miyake, Punit P. Seth, Audrey Low, Masayuki Yoshida, C. Frank Bennett, Kazunori Kataoka, Hidehiro Mizusawa, Satoshi Obika, Takanori Yokota, DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing Nature Communications. ,vol. 6, pp. 7969- 7969 ,(2015) , 10.1038/NCOMMS8969
Tamio Teramoto, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida, Shinji Kihara, Makoto Kinoshita, Chizuko Maruyama, Takao Ohta, Tomonori Okamura, Shizuya Yamashita, Masayuki Yokode, Koutaro Yokote, Mariko Harada-Shiba, Hidenori Arai, Hideaki Bujo, Atsushi Nohara, Takao Ohta, Shinichi Oikawa, Tomoo Okada, Akihiko Wakatsuki, Familial hypercholesterolemia: Executive summary of the Japan atherosclerosis society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version Journal of Atherosclerosis and Thrombosis. ,vol. 21, pp. 6- 10 ,(2014) , 10.5551/JAT.20040
E. Sehayek, S. Eisenberg, Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. Journal of Biological Chemistry. ,vol. 266, pp. 18259- 18267 ,(1991) , 10.1016/S0021-9258(18)55263-7
Shin-ichiro Hori, Tsuyoshi Yamamoto, Reiko Waki, Shunsuke Wada, Fumito Wada, Mio Noda, Satoshi Obika, Ca2+ enrichment in culture medium potentiates effect of oligonucleotides Nucleic Acids Research. ,vol. 43, ,(2015) , 10.1093/NAR/GKV626
Todd Burckin, Arthur A. Levin, Janet M. Leeds, Jon Fitchett, Richard S. Geary, Loanne Truong, Moire Creek, Charles Spainhour, Pharmacokinetics and Metabolism in Mice of a Phosphorothioate Oligonucleotide Antisense Inhibitor of C-raf-1 Kinase Expression Drug Metabolism and Disposition. ,vol. 25, pp. 1272- 1281 ,(1997)
Vivian E.H. Dahlmans, Louis M. Havekes, Theo J.C. van Berkel, Hans van der Boom, Miek C. Jong, Patrick C.N. Rensen, Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. Journal of Lipid Research. ,vol. 42, pp. 1578- 1585 ,(2001) , 10.1016/S0022-2275(20)32211-2
S T Crooke, K M Lemonidis, L Neilson, R Griffey, E A Lesnik, B P Monia, Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes Biochemical Journal. ,vol. 312, pp. 599- 608 ,(1995) , 10.1042/BJ3120599